Greenville, N.C. — When federal funding expired, Diannee Carden Glenn faced limited options.
Carden Glenn directs ekiM for Change, a volunteer-run public health organization serving Greenville and surrounding rural communities. For much of the past decade, she relied on federal Substance Abuse and Mental Health Services Administration funding to purchase drug test strips used to detect contaminants in the street‑drug supply.
In April, a federal “Dear Colleague” letter announced that organizations like hers could no longer use that funding for test strips targeting fentanyl, xylazine, medetomidine, or other overdose‑risk substances, particularly when users are unaware of what they consume.
Faced with lost support, Carden Glenn turned to personal resources. “I’m 81 years old, and I get Social Security,” she said. “So I use my Social Security. And I’m lucky to have a husband who can support me.” She also draws on other retirement income, allocating it to ekiM’s work, and occasionally accepts donations. The federal grant amounted to just over $15,000 annually.
Carden Glenn’s organization operates within the harm reduction movement, which seeks to keep people who use drugs safe. Critics argue that distributing test strips enables drug use and distracts from abstinence‑based recovery. Proponents counter that checking street drugs for contaminants is a proven overdose‑prevention strategy, especially given the proliferation of unknown substances. While fentanyl remains ubiquitous, front‑line workers increasingly find that street‑sold drugs unexpectedly contain methamphetamine and an rising range of ultrapotent synthetic compounds, including carfentanil, medetomidine, and nitazenes.
Research shows that individuals who use test strips are more likely to engage with other harm reduction services, such as carrying naloxone and avoiding solitary drug use.
In North Carolina, the federal agency served as the state opioid response program’s sole funding source for fentanyl and xylazine test strips, subsequently distributed to organizations statewide. These cuts represent part of a nationwide reduction exceeding $300 million in federal funding for overdose prevention and treatment initiatives.
North Carolina permits such groups to employ various drug‑checking tools. Carden Glenn’s organization typically distributes test strips for fentanyl, xylazine, and medetomidine. Test strips cost $1 or more each, depending on type; distributing several hundred weekly adds up quickly.
Test strips represent one category within a broader spectrum of tools used across the state.
Each Friday afternoon, 100 miles west of Greenville, the North Carolina Harm Reduction Coalition sets up at Elizabeth Street United Methodist Church in downtown Durham. There, team members operate a Fourier transform infrared spectroscopy device — a toaster‑oven‑sized machine that enables a more thorough examination than test strips, revealing the varied and sometimes startling contents of drugs submitted by users, their friends, family, or advocates.

Jennifer Carroll, associate professor of anthropology at North Carolina State University, partners with the Harm Reduction Coalition to evaluate testing results from this equipment. Supported by funding from the North Carolina Collaboratory, she finds each new drug sample a mystery in its chemical composition.
Those who visit the testing site range from regular to occasional users. Often, they enter unaware of what the sample may contain. “It just feels nice being able to offer this to people, and for them to have the power of having that knowledge,” Carroll said.
“We see quinine, lidocaine, tetracaine,” she said, seated behind the testing machine on a Friday afternoon in January. “We see tranquilizers like xylazine and medetomidine. We occasionally see gabapentin show up, but it’s not common. We occasionally see heroin.”

The spectroscopy device is not infallible; for instance, it may miss trace amounts of medetomidine in cocaine that a test strip would detect. Therefore, staff keep strips on hand as a complementary measure.
For more comprehensive analysis, the team submits samples to the Street Drug Analysis Lab at the University of North Carolina‑Chapel Hill — commonly known as “Nab’s Lab,” named for director Nabarun Dasgupta, 2025 MacArthur Fellowship “genius” grant recipient. Since the lab’s 2022 launch, its instrument has confirmed the chemical formula of approximately 500 unique substances in the drug supply. From rural Edgecombe County, for example, levamisole — an animal anti‑worm medication — was found. From Asheville, the industrial chemical BTMPS, used to protect plastics from ultraviolet exposure, turned up.
Pearson Ripley with the Steady Collective, a harm reduction organization in Asheville, identifies keeping pace with the flow of adulterants as the primary challenge for those doing this work. Previously, fentanyl’s emergence dominated concerns. Yet users have adapted. Now, the complexity of the unregulated supply poses the greatest difficulty. “Look at graphs charting the composition of street‑drug samples, Ripley said, “and it’s just, bam, stepping up every single year in the number of substances found in a supply.”
Thus, front‑line practitioners emphasize the urgent need for easily accessible drug testing.
Carroll highlighted the critical role that street‑drug suppliers can play in drug‑checking initiatives. “We’re still a very nascent service in North Carolina,” she noted; those relationships have yet to be firmly established. “But in many other places that have offered this service longer, some of their most impactful relationships are with suppliers who say, ‘I want to be able to communicate what I’m selling to other people so that no one is surprised.’”
Dasgupta has praised street‑drug checking strategies conceived and launched in rural communities, which he terms “engines of ingenuity.” He points to Holler Harm Reduction in rural western North Carolina, “where they’re going to people’s houses and doing driveway drug checking. That’s cool.”
The Good Mind Initiative, serving Indigenous communities across North and South Carolina, hosts monthly community socials at the United Karnuhuaka Longhouse, where up to 300 people gather for fellowship, food, first‑aid kits, naloxone, condoms, and more. Throughout each month, staff distribute supplies.
“Our identity, our culture, our language, our songs, our dances are integral to our healing and to our ability to help each other reduce harm,” said Kaya Littleturtle, the initiative’s program manager. Test strips — which they can no longer afford to provide — were once part of those offerings.

The organization stages fundraising events, including target‑shooting contests whose prizes are turkey or other meat. Still, replacing the lost federal investment would require substantial fundraising efforts.
In July 2025, President Donald Trump signed an executive order directing that federal grants not be spent on “so‑called ‘harm reduction’” efforts, writing that they “only facilitate illegal drug use and its attendant harm.”
That order and subsequent funding cuts have contributed to what North Carolina Harm Reduction Coalition executive director Elyse Powell describes as “an incredibly hostile time” for critical services.
Carroll reports that some federally qualified health centers have declined to participate in events associated with the term “drug checking.”
In May, U.S. Senator Ed Markey (D‑Mass.) sent a letter — co‑signed by four fellow senators and 16 House Democrats — to the Substance Abuse and Mental Health Services Administration asserting that its recent directive “defies evidence showing that harm reduction for substance use reduces overdose deaths and dangerous infections, threatening to reverse years of progress in combating the overdose epidemic.”
“To abandon harm reduction is to do so at our own peril,” Markey wrote.
The federal Centers for Disease Control and Prevention has acknowledged that test strips can be “the difference between life or death,” Markey added.
Margaret Bordeaux, a longtime harm reduction advocate, reflected: “I know people who have done amazing things, incredible work, to really advance drug testing here in North Carolina, and the impact that’s having on communities.” She added: “I know exactly what happens when those resources aren’t available in communities. We lived through it, and to think we’d have to go through it again is sad. It’s sad.”
Littleturtle agrees: “It’s just a hard time right now, because of politics, and politics should never get in the way of saving lives,” he said. “But it does.”

